Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for SPRB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 19.12M
March 31, 2026 21.52M
December 31, 2025 10.50M
September 30, 2025 9.927M
June 30, 2025 8.64M
March 31, 2025 16.32M
December 31, 2024 16.39M
September 30, 2024 13.46M
June 30, 2024 16.35M
March 31, 2024 20.92M
December 31, 2023 27.44M
September 30, 2023 27.60M
June 30, 2023 29.40M
March 31, 2023 31.12M
Date Value
December 31, 2022 17.16M
September 30, 2022 16.82M
June 30, 2022 15.39M
March 31, 2022 14.74M
December 31, 2021 15.12M
September 30, 2021 15.37M
June 30, 2021 13.34M
March 31, 2021 13.27M
December 31, 2020 13.46M
September 30, 2020 14.48M
June 30, 2020 9.622M
March 31, 2020
December 31, 2019 7.516M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Biogen, Inc. 13.24B
PTC Therapeutics, Inc. 3.416B
ACADIA Pharmaceuticals, Inc. 436.29M
Alnylam Pharmaceuticals, Inc. 4.205B
Anika Therapeutics, Inc. 46.19M

Total Liabilities (Quarterly) Related Metrics